STAT3 and breast carcinoma: We have previously shown that SDC1 expression affects cancer stem cell-related pathway components, including IL-6/STAT3, Notch, and EGFR signaling pathways, in SUM-149 triple-negative inflammatory breast cancer cells, an aggressive and deadly form of breast cancer [69].